5. ▪ Tablets are projected to generate a revenue of exceeding USD 100 billion by the end of 2025.
Increased prevalence of multivitamin products in the form of tablets on account of comfortable
dosage patterns is projected to have a substantial impact over the next eight years.
▪ Pregnant women segment reported a revenue of USD 12.55 billion in 2015. Rising importance of
folic acid based nutraceuticals for fetal development during the initial stage of pregnancy is
projected be a key market trend.
▪ Asia Pacific is expected to foresee the fastest growth at a CAGR of 11.2% from the period of 2016
to 2024. The strong foothold of middle-class income groups in China, India, Bangladesh,
Pakistan, and Thailand is expected to force the nutraceuticals manufacturers to invest in the
above-mentioned countries.
▪ Key manufacturers dominating the Dietary Supplement market are Amway, Archer Daniels
Midland Company, Abbott Laboratories, Bayer, Glanbia, Arkopharma Laboratories
Pharmaceuticals, Glaxo SmithKline. Strengthening product length and capital expansion are
expected to remain a key critical success factor for the industry for coming years.
▪ In February 2016, NBTY, Inc., agreed to sell Vitamin World, a U.S retail business to Centre Lane
Partners. This agreement is a standalone business with investment and resources tailored to
retail business operations. This strategy is expected to benefit the company to position itself in
the market with long-term growth and success.